Gilead Sciences (GILD)

EBITDA

$1.33B

TTM · Period ending: · USD

GILD logo

GILD EBITDA

Latest reported$1.33B
GILD EBITDA (-$4.00M → $1.33B)
High-resolution chart · PNG

GILD ebitda history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Gilead Sciences EBITDA — Annual fiscal periods (USD)
Period endingEBITDA (USD)
13,580,000,000
4,434,000,000
10,496,000,000
8,852,000,000
11,329,000,000
4,133,000,000
7,559,000,000
10,305,000,000
15,933,000,000
19,219,000,000
23,445,000,000
16,318,000,000
4,860,000,000
4,251,000,000
4,158,654,000
4,287,986,000
3,784,562,000
2,893,552,000
2,215,786,000
1,682,582,000
1,144,844,000
651,795,000
350,783,000
95,435,000
-105,998,000
-40,310,000
-39,100,000
-65,100,000
-56,900,000
-31,600,000
-28,800,000
-31,300,000
-16,500,000
-5,300,000
-4,000,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.